SCHEMBL20254282

SCHEMBL20254282

N#Cc1cc(C#N)cc(-c2ccc(-c3cc4c(-c5ccccc5)c5sccc5c(-c5ccccc5)c4s3)cc2)c1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 2/20 0.32
▸ SLC22A12 Q96S37 2/20 0.32
▸ METAP2 P50579 1/20 0.32
▸ PTP4A3 O75365 1/20 0.32
▸ PTP4A2 Q12974 1/20 0.32
▸ PTP4A1 Q93096 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ PDE2A O00408 1/20 0.32
▸ HPGDS O60760 1/20 0.31
▸ CHEK1 O14757 1/20 0.31
▸ SLC6A2 P23975 1/20 0.31
▸ SLC6A4 P31645 1/20 0.31
▸ SLC6A3 Q01959 1/20 0.31
▸ PTPN5 P54829 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ MEN1 O00255 3/20 0.31
▸ KMT2A Q03164 3/20 0.31
▸ GABRA1 P14867 1/20 0.31
▸ GABRG2 P18507 1/20 0.31
▸ GABRB3 P28472 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20254262 0.94 HPGDS (0.33) METAP2PTP4A3PTP4A2PTP4A1PDE2A
SCHEMBL20248909 0.94 METAP2 (0.34) XDHSLC22A12METAP2PTP4A3PTP4A2
SCHEMBL20254261 0.85 ADORA2A (0.43) ADORA2AMEN1KMT2AUSP2LMNA
SCHEMBL20254263 0.84 HPGDS (0.37) XDHSLC22A12METAP2PTP4A3PTP4A2
SCHEMBL20254266 0.84 CYP1A1 (0.38) METAP2PTP4A3PTP4A2PTP4A1HPGDS
SCHEMBL20248875 0.82 ADORA2A (0.43) ADORA2AMEN1KMT2ACYP1A1CYP1B1
SCHEMBL20248873 0.82 ADORA2A (0.45) PTP4A3PTP4A2PTP4A1ADORA2AMEN1
SCHEMBL20248872 0.81 ADORA2A (0.46) PTP4A3PTP4A2PTP4A1ADORA2AMEN1
SCHEMBL20248869 0.79 ADORA2A (0.42) PTP4A3PTP4A2PTP4A1ADORA2AMEN1
SCHEMBL28855928 0.79 ADORA2A (0.39) METAP2CYP19A1ADORA2AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10347846-B2 Organic compound for organic EL device and using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-07-09 — — US disclosed
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10347846-B2 Organic compound for organic EL device and using the same L1CAM, ESR1, XPO4 XDH 296/4885SLC22A12 1084/4885METAP2 3470/4885
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME L1CAM, ESR1, XPO4 XDH 296/4885SLC22A12 1084/4885METAP2 3470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback